Our research team studies the genetics and epigenetics of human solid tumours, with special emphasis on colorectal cancer, testicular cancer, and nerve cancer. To gain knowledge of the complex dynamics of cancer development we combine large-scale and detailed biology research using in vitro models and clinical samples. Our goal is to bring results from molecular biology into clinical utility.
The Cell Signalling project group led by Edward Leithe is also a part of this group.
Diseases we research
Topics we research
Biomarkers for early detection, prognosis and prediction
Department of Molecular Oncology, Institute for Cancer Research
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 2278 1728, Switchboard: +47 2293 4000, Fax: +47 2278 1745
Aug 25, 2016
Aug 11, 2016
Aug 3, 2016
Jun 29, 2016
Epigenetic Disruption of miR-130a Promotes Prostate Cancer By Targeting SEC23B and DEPDC1
Cancer Lett, 385, 150-159